Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
The treatment of cancer remains a significant challenge in modern medicine, with conventional therapies often associated with severe side effects and limited efficacy. In recent years, there has been a growing interest in developing novel drug delivery systems for targeted cancer therapy. This thesis focuses on the design and development of such systems aimed at improving the effectiveness and reducing the adverse effects of cancer treatment. The introduction provides a comprehensive overview of the current landscape of cancer therapy, highlighting the limitations of existing approaches and the need for innovative solutions. The background of the study delves into the underlying principles of targeted drug delivery and the potential benefits it offers in the context of cancer treatment. The problem statement identifies the gaps in current research and practice, setting the stage for the objectives of the study. The primary objective of this research is to design and evaluate novel drug delivery systems specifically tailored for targeting cancer cells while minimizing harm to healthy tissues. Through an extensive literature review, key insights are gathered on the latest advancements in drug delivery technologies, including nanomedicine, liposomes, and polymer-based carriers. The review encompasses ten critical aspects that inform the development of the proposed drug delivery systems. The research methodology section outlines the experimental approach adopted in this study, covering essential aspects such as materials selection, formulation techniques, in vitro and in vivo testing methodologies, and data analysis procedures. The methodology aims to provide a robust framework for designing, fabricating, and characterizing the novel drug delivery systems. Chapter four presents a detailed discussion of the findings obtained from the experimental investigations. The results showcase the efficacy of the developed drug delivery systems in selectively targeting cancer cells, delivering therapeutic agents efficiently, and demonstrating improved treatment outcomes compared to conventional approaches. The discussion also addresses the challenges encountered during the research and proposes potential strategies for overcoming them. Finally, the conclusion and summary chapter consolidate the key findings of the study, emphasizing the significance of the developed drug delivery systems in advancing targeted cancer therapy. The thesis concludes with recommendations for future research directions and practical implications for translating the novel systems into clinical applications. In conclusion, this thesis contributes to the field of cancer therapy by proposing innovative drug delivery systems that hold promise for enhancing treatment outcomes and improving the quality of life for cancer patients. The research underscores the importance of continued innovation in drug delivery technologies to address the complexities of cancer treatment and pave the way for more effective and personalized therapeutic interventions.